ES104

· Elpiscience (Suzhou) Biopharma, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ES104, covering 2023-02-15 to 2023-02-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ES104 in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]